IP Library › Granted Patent US 8,067,368
Granted Patent B2
US 8,067,368 · App. 10/597,509 · Granted Nov 29, 2011

Vascular endothelial growth factors and methods of their use

Assignees: The Ohio State University Research Foundation; Nationwide Children's Hospital, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,067,368
App. No.
10/597,509
Granted
Nov 29, 2011
Kind
B2
Abstract

Vascular endothelial growth factor alternative splice variants and methods of their use are provided.

Claims (8)

1. An isolated or purified polypeptide comprising amino acids 27 through 171 of SEQ ID NO: 1.

2. A method of inducing migration and survival of vascular endothelial cells, comprising administering to the cells an effective amount of the polypeptide according to claim 1 .

3. An implantable medical device or implant coated with a polypeptide according to claim 1 .

4. The device or implant according to claim 3 , wherein the device or implant is a suture.

5. An additive for cell culture medium comprising the polypeptide according to claim 1 .

6. A cell culture medium comprising the polypeptide according to claim 1 .

7. An isolated or purified polypeptide consisting of amino acids 27 through 171 of SEQ ID NO: 1.

8. An isolated or purified polypeptide comprising SEQ ID NO: 1.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 22, 2020
From: THE OHIO STATE UNIVERSITY
To: NIH - DEITR
Reel/Frame 053569/0354 →
CONFIRMATORY LICENSE Recorded Apr 23, 2008
From: OHIO STATE UNIVERSITY RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020843/0326 →
Continuity (2)
Provisional Application 60539852 · Jan 27, 2004
Related Publication 20080299167A1 · Dec 4, 2008